(Q33557284)

28 July 2017

title

Long-term treatment of rheumatoid arthritis with sulphasalazine, gold, or penicillamine: a comparison using life-table methods (English)

1 reference

28 July 2017

1 reference

1 reference

Situnayake RD

1

1 reference

28 July 2017

Grindulis KA

series ordinal

2

1 reference

28 July 2017

McConkey B

series ordinal

3

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 March 1987

1 reference

Annals of the Rheumatic Diseases

28 July 2017

published in

1 reference

28 July 2017

volume

46

1 reference

28 July 2017

issue

3

1 reference

28 July 2017

page(s)

177-183

1 reference

The toxicity pattern of D-penicillamine therapy. A guide to its use in rheumatoid arthritis

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1002096

An overview of benefit/risk of disease modifying treatment of rheumatoid arthritis as of today

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1002096

Outcome of attempts to treat rheumatoid arthritis with gold, penicillamine, sulphasalazine, or dapsone

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1002096

Sulfasalazine intolerance. A retrospective survey of the reasons for discontinuing treatment with sulfasalazine in patients with chronic inflammatory bowel disease

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1002096

Sulphasalazine desensitisation.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1002096

Practical results of treatment with disease-modifying antirheumatoid drugs.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1002096

Sulphasalazine: a safe, effective agent for prolonged control of rheumatoid arthritis. A comparison with sodium aurothiomalate

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1002096

An assessment of penicillamine therapy in rheumatoid arthritis and the influence of previous gold therapy

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1002096

Long term chrysotherapy: incidence of toxicity and efficacy during sequential time periods

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1002096

Reinstitution of gold therapy in rheumatoid arthritis after mucocutaneous reactions

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1002096

Drug treatment of rheumatoid arthritis. A systematic approach

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1002096

Inhibition of Folate Enzymes by Sulfasalazine

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1002096

Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1002096

Cyclophosphamide, gold and penicillamine--disease-modifying drugs in rheumatoid arthritis--tailored dosage and ultimate success

31 October 2018

1 reference

12 December 2020

Sulphasalazine in rheumatoid arthritis

1 reference

12 December 2020

Analysis of treatment terminations with gold and antimalarial compounds in rheumatoid arthritis

1 reference

12 December 2020

A biochemical assessment of sulphasalazine in rheumatoid arthritis

1 reference

12 December 2020

Terminations of treatment with gold sodium thiomalate in rheumatoid arthritis

1 reference

12 December 2020

Sulphasalazine in the treatment of rheumatoid arthritis: relationship of dose and serum levels to efficacy

1 reference

12 December 2020

Does sulphasalazine cause folate deficiency in rheumatoid arthritis?

1 reference

12 December 2020

Identifiers

DOI

10.1136/ARD.46.3.177

1 reference

release_lftv5egvcrfrrns6bx2w2643zi

28 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/lftv5egvcrfrrns6bx2w2643zi

24 November 2022

mapped directly with Wikidata item

PMC publication ID

1002096

1 reference

28 July 2017

1 reference